share_log

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $5 Price Target

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $5 Price Target

HC Wainwright & Co.重申在 Affimed 上买入,维持5美元的目标股价
Benzinga ·  2023/11/15 08:30

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:AFMD) with a Buy and maintains $5 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth重申了Affimed(纳斯达克股票代码:AFMD)的买入,并维持5美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发